The industry was thrown into a "hotly-contested" debate about how to handle this mystery. To provide a roadmap, the Parenteral Drug Association (PDA) formed a task force of experts from the , academia, and the pharmaceutical industry. After three years of intensive work, they published Technical Report No. 82 (TR 82)
This report provides a science-based framework for understanding, detecting, and mitigating Low Endotoxin Recovery (LER)—a masking effect that can prevent the reliable detection of endotoxins in biologics. pda technical report 82
When these components interact, they can disrupt the ability of LAL reagents to detect bacterial endotoxins, posing a significant risk to patient safety as potential contaminants might go unnoticed. Core Objectives of TR 82 The industry was thrown into a "hotly-contested" debate
